FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804633214> ?p ?o ?g. }

• W2804633214 endingPage "1552" @default.
• W2804633214 startingPage "1538" @default.
• W2804633214 abstract "Access to affordable lifesaving medicines is considered a human right. This leads to a question largely understudied in the catch-up literature on accumulation of industrial capabilities. Can the need to improve access to an essential commodity impact the sectoral catch-up trajectory of the corresponding industry? In 1996, Brazil initiated a policy of universal and free access to highly-active ARV therapy, which put an enormous pressure on the Brazilian Ministry of Health (MoH). In order to ensure an adequate supply of ARVs in the public healthcare system with a limited budget, MoH started negotiating price reductions for high-cost patented drugs, often deploying the threat of using compulsory licensing. Through a scoping review of the literature and construction of the Brazilian case study, the paper explores how the need to access is impacted by prior catch-up in the pharmaceutical sector and triggers in turn future sectoral catch-up. It shows that price negotiations may or may not impact both catch-up and access positively. Catch-up can provide bargaining strength in price negotiations and have a positive inter-temporal impact on both future catch-up and access. However, results suggest that only successful catch-up can lead to long term access, as the capabilities accumulated in aborted catch-up are not sufficient for large scale production of low cost essential medicines. Thus, industrial policy and health policy can impact one another and twining between catch-up and access can be helpful." @default.
• W2804633214 created "2018-06-01" @default.
• W2804633214 creator A5052284335 @default.
• W2804633214 creator A5083923003 @default.
• W2804633214 date "2018-10-01" @default.
• W2804633214 modified "2023-10-18" @default.
• W2804633214 title "When access to drugs meets catch-up: Insights from the use of CL threats to improve access to ARV drugs in Brazil" @default.
• W2804633214 cites W142261278 @default.
• W2804633214 cites W1484783081 @default.
• W2804633214 cites W1548224563 @default.
• W2804633214 cites W1750978169 @default.
• W2804633214 cites W1818167564 @default.
• W2804633214 cites W1965217122 @default.
• W2804633214 cites W1965531103 @default.
• W2804633214 cites W1967860322 @default.
• W2804633214 cites W1970626586 @default.
• W2804633214 cites W1979944077 @default.
• W2804633214 cites W1980548281 @default.
• W2804633214 cites W1981334078 @default.
• W2804633214 cites W1987698199 @default.
• W2804633214 cites W1988198807 @default.
• W2804633214 cites W1989361694 @default.
• W2804633214 cites W1990187313 @default.
• W2804633214 cites W1992458409 @default.
• W2804633214 cites W1993551908 @default.
• W2804633214 cites W1998182540 @default.
• W2804633214 cites W1999240518 @default.
• W2804633214 cites W2000586461 @default.
• W2804633214 cites W2003318188 @default.
• W2804633214 cites W2005736351 @default.
• W2804633214 cites W2005928537 @default.
• W2804633214 cites W2007788899 @default.
• W2804633214 cites W2009636604 @default.
• W2804633214 cites W2020039596 @default.
• W2804633214 cites W2022278020 @default.
• W2804633214 cites W2022927530 @default.
• W2804633214 cites W2026770073 @default.
• W2804633214 cites W2030704643 @default.
• W2804633214 cites W2032812673 @default.
• W2804633214 cites W2032966887 @default.
• W2804633214 cites W2040668725 @default.
• W2804633214 cites W2043137453 @default.
• W2804633214 cites W2043668630 @default.
• W2804633214 cites W2047299297 @default.
• W2804633214 cites W2051079330 @default.
• W2804633214 cites W2051309457 @default.
• W2804633214 cites W2055767977 @default.
• W2804633214 cites W2068085580 @default.
• W2804633214 cites W2071581967 @default.
• W2804633214 cites W2077756998 @default.
• W2804633214 cites W2081494404 @default.
• W2804633214 cites W2082913387 @default.
• W2804633214 cites W2084815225 @default.
• W2804633214 cites W2086555666 @default.
• W2804633214 cites W2087000688 @default.
• W2804633214 cites W2089990993 @default.
• W2804633214 cites W2090578047 @default.
• W2804633214 cites W2094588544 @default.
• W2804633214 cites W2096788819 @default.
• W2804633214 cites W2100666955 @default.
• W2804633214 cites W2104489459 @default.
• W2804633214 cites W2106423535 @default.
• W2804633214 cites W2116969121 @default.
• W2804633214 cites W2118730338 @default.
• W2804633214 cites W2120599827 @default.
• W2804633214 cites W2123472049 @default.
• W2804633214 cites W2126264646 @default.
• W2804633214 cites W2128096549 @default.
• W2804633214 cites W2131957821 @default.
• W2804633214 cites W2133445738 @default.
• W2804633214 cites W2136615848 @default.
• W2804633214 cites W2137124541 @default.
• W2804633214 cites W2137130301 @default.
• W2804633214 cites W2144471385 @default.
• W2804633214 cites W2149550142 @default.
• W2804633214 cites W2152506760 @default.
• W2804633214 cites W2157774440 @default.
• W2804633214 cites W2157975985 @default.
• W2804633214 cites W2160140955 @default.
• W2804633214 cites W2161016869 @default.
• W2804633214 cites W2162034479 @default.
• W2804633214 cites W2166243753 @default.
• W2804633214 cites W2168667098 @default.
• W2804633214 cites W2169192117 @default.
• W2804633214 cites W2169285633 @default.
• W2804633214 cites W2278217494 @default.
• W2804633214 cites W2465025564 @default.
• W2804633214 cites W2470221637 @default.
• W2804633214 cites W2528634948 @default.
• W2804633214 cites W2531648324 @default.
• W2804633214 cites W2546887909 @default.
• W2804633214 cites W3123121588 @default.
• W2804633214 cites W3123909483 @default.
• W2804633214 cites W3125811413 @default.
• W2804633214 cites W4231859007 @default.
• W2804633214 cites W4239918286 @default.
• W2804633214 doi "https://doi.org/10.1016/j.respol.2018.05.008" @default.
• W2804633214 hasPublicationYear "2018" @default.

• next